http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0211098-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
filingDate | 2002-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34da0a1f54d28055ffd0f1ebe9b29539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a09976dc0c0beb684768a900ec8a62e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca674b001560863c41dd938b1eda67f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b37c1d95e1756f889551d4ac7ee44892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cabe58dfd1b2af907f6fb647d6b766d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6f33a48f5443638c882a12da8339e2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ed2e3556eb26d28e0deba0d53f7ad8 |
publicationDate | 2004-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-0211098-A |
titleOfInvention | Compounds and methods for trypanosoma cruzi inhibition |
abstract | "COMPOUNDS AND METHODS FOR INHIBITING TRYPANOSOMA CRUZI". The present invention relates to compounds according to formula (1): wherein RA is a substituted or unsubstituted branched chain or cyclic C1 -C10 alkyl or straight alkenyl group or a phenyl group according to formula (1). 11): RB is a substituted or unsubstituted branched chain or straight chain C1 -C10 alkyl or alkenyl group or a phenyl group according to formula (III): R1, R2, R3, R4, R5, R6, R 7, R 8, R 9 and R 10 are each independently selected from H, C 1 -C 10 (preferably a C 1 -C 4) alkyl or alkenyl group, CF 3, F, CI, Br, I, CN, NO 2, NH 2, NHR, NRR, COR (acyl group), OR (hydroxyl or ether group), CO2R (carboxylic acid or ester group), or COSR (thioester group), where R is H or a C1-C10 (preferably a C1-C4) alkyl or alkenyl group , an unsubstituted or substituted aryl (preferably phenyl) group or heterocycle group, or a group (IV), where R 3 is H, a C 1 -C 2 -C 10 (preferably a C 1 -C 4) alkyl group alkenyl, ether or thioester; and R 11 and R 12 are independently selected from H or a C 1 -C 3 alkyl or alkenyl group, or a pharmaceutically acceptable salt thereof and methods for treating infections caused by protozoal, fungal and / or bacterial agents such as Trypanosoma cruzi, Mycobacterium spp., Leishmania spp., Cryptococcus spp., Aspergillus spp., Histoplasma spp., Candida spp., Especially Candida albicans, Pneumocystis carinii, Trichophyton spp., Malassezia spp. Coccidiodes spp., Among others. |
priorityDate | 2001-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.